Perceptive Xontogeny Venture Fund, LP (CIK 0001757940)

Latest company ownership

LIANY - LianBio
Role: Director
Shares held
53,829,960
Last filed at
Aug 22, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q4 2025Q4
Shares held
1,611,699
Last filed at
Feb 5, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2022Q4 2025Q4
Shares held
73,107
Last filed at
Jan 12, 2024
Confidence Score
50.6
2025Q4
Confidence Score History
2024Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 19, 2025 Feb 21, 2025 Solid Biosciences Inc. Director Buy 100.0 +5,000,000 73.17% ✗ $20.2M
Feb 1, 2024 Feb 5, 2024 Astria Therapeutics, Inc. Director Buy 100.0 +2,481,350 103.72% ✗ $30M
Jan 11, 2024 Jan 12, 2024 Solid Biosciences Inc. Director Buy 100.0 +3,410,713 99.65% ✗ $18.9M
Dec 21, 2023 Dec 22, 2023 Astria Therapeutics, Inc. Director Buy 100.0 +740,000 44.78% ✗ $4.6M
Oct 16, 2023 Oct 18, 2023 Astria Therapeutics, Inc. Director Buy 100.0 +1,074,608 49.08% ✗ $7M
Dec 19, 2022 Dec 21, 2022 Astria Therapeutics, Inc. Director Buy 100.0 +908,265 698.43% ✗ $10M
Aug 18, 2022 Aug 22, 2022 LianBio Director Buy 87.5 +998,240 1.76% ✗ $2.4M
May 26, 2022 May 27, 2022 LianBio Director Buy 60.0 +69,000 0.12% ✗ $216K
May 23, 2022 May 25, 2022 LianBio Director Buy 67.5 +171,251 0.30% ✗ $442.4K
Nov 3, 2021 Nov 5, 2021 LianBio Director Buy 97.5 +2,270,000 8.87% ✗ $36.3M
Nov 1, 2021 Nov 3, 2021 LianBio 10% Owner Buy 92.5 +220,000 3.13% ✗ $3.2M